🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes
Article digest · Oct 25 AM

AI & Finance — what each story says

Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.

23 stories4 with summaries8 topics

🏦 Banks2

🛡️ Insurance2

Yahoo Finance10/24 10:00 UTC

Apple's new hardware push is meeting AI-worried investors at the right moment

Apple offers a hardware refuge during a moment of AI volatility.

Read the original →

💼 Asset Management4

AI Insider10/24 17:51 UTC

Pathos AI Secures $237M in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline

Pathos AI, a New York-based clinical-stage AI and technology company developing its own drugs, has closed a $237 million Series E.

Read the original →

📊 Markets / Trading4

TradingView10/24 13:22 UTC

VisionSys AI Inc. Estimates – NASDAQ:VSA

The page compares VisionSys AI Inc.'s actual results with analyst expectations. It covers revenue, earnings, cash flow and valuation estimates.

Read the original →

💳 Fintech / Payments2

🚀 AI Stocks / Funding5

⚖️ Financial Regulation / Supervision1

🗾 Japan's Finance and AI3

BigGo Finance10/24 12:05 UTCJapanese

Nvidia CEO Huang Proposes Using Chips as Loan Collateral to Raise $500 Billion for AI Build-Out

Nvidia CEO Jensen Huang is urging lenders to accept the company's AI chips as collateral for loans. The effort aims to mobilize more than $500 billion in funding for AI infrastructure.

Read the original →
The analysis and visual summary are in the Oct 25 AM issue. Japanese version here.